RETRACTION: Experimental Liver Cirrhosisにおける酸化ストレスと肺の変化
Oxidative medicine and cellular longevity
|January 7, 2026
まとめ
この記事は撤回されました。DOI: 10.1155/2012/486190で特定された元の研究は、もはや有効または科学的記録の一部とはみなされません。
科学分野:
- 科学出版物の撤回通知。
背景:
- これは、以前に出版された記事の撤回通知として機能します。
研究 の 目的:
- DOI: 10.1155/2012/486190で特定された記事を正式に撤回すること。
主な方法:
- 出版社によって開始された正式な撤回プロセス。
主要な成果:
- DOI: 10.1155/2012/486190の記事は正式に撤回されました。
結論:
- 撤回された記事の内容は引用または参照されるべきではありません。
関連する概念動画
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
210
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
210
Phase I Oxidative Reactions: Overview
703
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
703


